Alight names Dinesh Tulsiani president, Susan Davies interim CFO

Alight Inc. (NYSE: ALIT) announced two executive leadership appointments, naming Dinesh Tulsiani as President of Employer Solutions and Susan Davies as Interim Chief Financial Officer.

Tulsiani will assume his role effective May 1, 2026, reporting directly to Chief Executive Officer Rohit Verma. He will lead the Employer Solutions business alongside Alight's Health and Leaves Solution Leaders, Strategy, User Experience and Value Engineering teams.

Davies, currently Chief Accounting Officer and Global Controller, will serve as Interim CFO starting May 8, 2026, following the previously announced departure of Greg Giometti. The company said it will conduct a search for a permanent CFO while Giometti remains through May 8 to support the transition.

Tulsiani previously served as Alight's Chief Strategy Officer from September 2017 to February 2025, where the company said he was instrumental in driving growth including expansion into health navigation, global payroll, and voluntary benefits. He departed and served in advisory roles before rejoining Alight in an advisory capacity in January 2026.

Before his initial tenure at Alight, Tulsiani led corporate development for Aon's HR Solutions segment and held senior strategic roles at Aon and Hewitt Associates. He also worked at IHS Markit and EY.

Davies has served as Chief Accounting Officer and Global Controller since May 2021, overseeing global controllership and external and regulatory reporting. She joined Alight from Willis Towers Watson, where she held various roles from 2007 to 2021, including Principal Accounting Officer and Global Controller. Prior to that, she spent 10 years at PwC in Global Risk Assurance.

Alight provides benefits administration services for health, wealth, leave and point solutions to organizations and over 30 million people.

You May Also Be Interested In

• Middleby board approves spin-off of food processing unit Midera
• FibroBiologics receives U.S. patent allowance for wound healing therapy
• AMTD group discloses share repurchase totals, plans to expand buybacks